Amogen Pharma

Amogen's aim and its core business model is to provide these generic peptides and biosimilars to patients worldwide and thus, help to improve their lives. We are committed to developing therapeutic products that we believe have best-in-class potential, meaning therapies that have the potential to be safer and more effective than the current standard of care or other products in development, and that may have other advantages, such as superior scalability or ease of administration. We are passionate about transforming patients' lives. We are courageous in both decision and action. And we believe that good business means a better world.